Francesc Bosch

机构：Hebron University, Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari · ORCID：0000-0001-9241-2886

发表论文 493 篇 · 总被引 15976 次 · h-index 61

代表论文

• Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial (2025 · Journal of Clinical Oncology · 被引 13)
• CLL-984: CLL18/MOIRAI International Phase 3 Trial: Aiming to Establish Measurement of Individual Residual Disease for Adjustment of Treatment Duration to Improve Outcomes in First-Line Treatment of CLL/SLL (2025 · Clinical Lymphoma Myeloma & Leukemia · 被引 4)
• Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition (2026 · Blood Advances · 被引 1)
• Refining the prognostic hierarchy of TP53 multihit alterations and isolated deletion of chromosome 5q in myelodysplastic syndromes (2025 · Blood · 被引 1)
• Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study (2025 · Leukemia · 被引 1)
• Implementation of the precision oncology program in catalonia’s public health system: results, lessons learned, and future prospects (2025 · Clinical & Translational Oncology · 被引 1)